(Q39487830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

David Niederseer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Elisabeth Haschke-Becher

11

object named as

Elisabeth Haschke-Becher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Alexandra Feldman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sebastian K Eder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Lyudmyla Kedenko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Bernhard Paulweber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Andreas Stadlmayr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Ursula Huber-Schönauer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Felix Stickel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Simon Auer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Wolfgang Patsch

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Christian Datz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Elmar Aigner

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

English

0 references

publication date

16 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

102-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Lean NASH: distinctiveness and clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Food, immunity, and the microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

[S2k Guideline non-alcoholic fatty liver disease].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

International physical activity questionnaire: 12-country reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

MetaboAnalyst: a web server for metabolomic data analysis and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

MetaboAnalyst 3.0--making metabolomics more meaningful

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

More powerful procedures for multiple significance testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

pROC: an open-source package for R and S+ to analyze and compare ROC curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Nonalcoholic fatty liver disease in lean individuals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Variations in BMI and prevalence of health risks in diverse racial and ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Oxidized LDL and expression of monocyte adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Alterations of plasma lysophosphatidylcholine species in obesity and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Altered plasma lysophosphatidylcholines and amides in non-obese and non-diabetic subjects with borderline-to-moderate hypertriglyceridemia: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Plasma metabolomic profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Finding the balance: the role of S-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.318

Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

21 January 2018

1 reference

12 December 2020

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages

1 reference

12 December 2020

Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects

1 reference

12 December 2020

The genetics of NAFLD.

1 reference

12 December 2020

Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults

1 reference

12 December 2020

Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

PNPLA3gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

1 reference

12 December 2020

2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice

1 reference

12 December 2020

Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease

1 reference

12 December 2020

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2016.318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27527746%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference